EpiStem Ltd

Industry:	Pharmaceuticals, Biotechnology
Revenues:	Under $20 Million
Employees:	29

Description

EpiStem Holdings Plc is a biotechnology company commercializing epithelial stem cells in the areas of oncology, gastrointestinal diseases and dermatology. Epistem provides specialized preclinical efficacy testing, biomarker services and the development of therapies for partner companies across the biotechnology and pharmaceutical drug development industries. Its Novel Therapies division is focused on developing its own therapeutics based on its discovery of key regulators of epithelial cell production. Epistem is developing a non-invasive test for pharmaceutical companies developing new drugs, initially in the area of oncology. The Company’s Contract Research Services provides specialized preclinical efficacy testing primarily for drug development companies on a fee for service basis.
(Source: ARS)

Products & Services

epithelial stem cell, pre-clinical contract research service, pre-clinical research services

News Archive

Epistem has a "transformational" year. Investors Chronicle - magazine and web content; 10/6/2009 Byline: Nigel Bolitho Epistem has turned out to be a wonder baby bio...replenish their drug pipe lines. But Epistem's performance in share price terms...at GBP600,000. On the same basis Epistem's Biomarker division turned in a small... ...more

Aeolus Pharmaceuticals Reports on Recent Experiments in Preclinical Models. Entertainment Close-up; 10/26/2009 ...Director, Contract Research Services at Epistem. "This is one of few drugs shown to...These studies are being conducted by Epistem, a subcontractor of the University of...the event of a terrorist nuclear act. Epistem operates a contract research organization... ...more

Epistem non-exec sells after price surge in 2009. Investors Chronicle - magazine and web content; 10/15/2009 ...million-pound sales this week The chief scientific adviser to Epistem Holdings, Dr Chris Potten, has sold GBP1.4m worth of shares...expansion of a US government bio-defence contract, in which Epistem screens drugs designed to protect soldiers from radiation exposure... ...more